INTEGRA LIFESCIENCES HOLDINGS CORP Cost of Goods Sold (Deprecated 2018-01-31)
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Cost of Goods Sold (Deprecated 2018-01-31) of $144.22 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-04-26.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2018-04-26
- INTEGRA LIFESCIENCES HOLDINGS CORP cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $144.22M, a 66.57% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $148.17M, a 73.46% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $101.76M, a 13.91% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $99.00M, a 10.53% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $435.51M, a 24.76% increase from fiscal 2016.
- INTEGRA LIFESCIENCES HOLDINGS CORP cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $349.09M, a 6.90% increase from fiscal 2015.
- INTEGRA LIFESCIENCES HOLDINGS CORP cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $326.54M, a 7.79% increase from fiscal 2014.
- INTEGRA LIFESCIENCES HOLDINGS CORP cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $302.95M, a 8.37% increase from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 3 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 12 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $144.22M 10-Q · filed 2018-04-26 | $292.39M derived: sum of 2 quarters · filed 2018-04-26 | $394.15M derived: sum of 3 quarters · filed 2018-04-26 | $493.15M derived: sum of 4 quarters · filed 2018-04-26 | ||||
| 2017-12-31 | $148.17M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $249.93M derived: sum of 2 quarters · filed 2018-03-01 | $348.93M derived: sum of 3 quarters · filed 2018-03-01 | $435.51M 10-K · filed 2018-03-01 | ||||
| 2017-09-30 | $101.76M 10-Q · filed 2017-10-26 | $200.75M derived: sum of 2 quarters · filed 2017-10-26 | $287.34M 10-Q · filed 2017-10-26 | $372.76M derived: sum of 4 quarters · filed 2018-04-26 | ||||
| 2017-06-30 | $99.00M 10-Q · filed 2017-07-26 | $185.58M 10-Q · filed 2017-07-26 | $271.00M derived: sum of 3 quarters · filed 2018-04-26 | $360.33M derived: sum of 4 quarters · filed 2018-04-26 | ||||
| 2017-03-31 | $86.58M 10-Q · filed 2018-04-26 | $172.01M derived: sum of 2 quarters · filed 2018-04-26 | $261.34M derived: sum of 3 quarters · filed 2018-04-26 | $350.90M derived: sum of 4 quarters · filed 2018-04-26 | ||||
| 2016-12-31 | $85.42M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $174.75M derived: sum of 2 quarters · filed 2018-03-01 | $264.32M derived: sum of 3 quarters · filed 2018-03-01 | $349.09M 10-K · filed 2018-03-01 | ||||
| 2016-09-30 | $89.33M 10-Q · filed 2017-10-26 | $178.89M derived: sum of 2 quarters · filed 2017-10-26 | $263.67M 10-Q · filed 2017-10-26 | $353.67M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-06-30 | $89.56M 10-Q · filed 2017-07-26 | $174.34M 10-Q · filed 2017-07-26 | $264.34M derived: sum of 3 quarters · filed 2018-03-01 | $350.41M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | $84.77M 10-Q · filed 2017-04-26 | $174.77M derived: sum of 2 quarters · filed 2018-03-01 | $260.84M derived: sum of 3 quarters · filed 2018-03-01 | $336.09M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | $90.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $176.07M derived: sum of 2 quarters · filed 2018-03-01 | $251.32M derived: sum of 3 quarters · filed 2018-03-01 | $326.54M 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | $86.07M 10-Q · filed 2016-10-28 | $161.32M derived: sum of 2 quarters · filed 2016-10-28 | $236.54M 10-Q · filed 2016-10-28 | $321.56M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | $75.25M 10-Q · filed 2016-07-28 | $86.54M 10-Q · filed 2015-07-31 | $150.47M 10-Q · filed 2016-07-28 | $173.26M 10-Q · filed 2015-07-31 | $235.50M derived: sum of 3 quarters · filed 2017-02-23 | $309.39M derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2015-03-31 | $75.22M 10-Q · filed 2016-04-27 | $86.72M 10-Q · filed 2015-05-01 | $160.25M derived: sum of 2 quarters · filed 2017-02-23 | $234.14M derived: sum of 3 quarters · filed 2017-02-23 | $321.12M derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2014-12-31 | $85.02M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $158.92M derived: sum of 2 quarters · filed 2017-02-23 | $245.90M derived: sum of 3 quarters · filed 2017-02-23 | $302.95M 10-K · filed 2017-02-23 | $352.80M 10-K · filed 2015-02-27 | |||
| 2014-09-30 | $73.90M 10-Q · filed 2015-11-04 | $85.97M 10-Q · filed 2014-11-07 | $160.87M derived: sum of 2 quarters · filed 2015-11-04 | $217.92M 10-Q · filed 2015-11-04 | $255.33M 10-Q · filed 2014-11-07 | $279.60M derived: sum of 4 quarters · filed 2016-02-26 | ||
| 2014-06-30 | $86.98M 10-Q · filed 2015-07-31 | $169.36M 10-Q · filed 2015-07-31 | $205.70M derived: sum of 3 quarters · filed 2016-02-26 | $287.47M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $82.38M 10-Q · filed 2015-05-01 | $118.72M derived: sum of 2 quarters · filed 2016-02-26 | $200.49M derived: sum of 3 quarters · filed 2016-02-26 | $282.32M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $36.34M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $118.11M derived: sum of 2 quarters · filed 2016-02-26 | $199.94M derived: sum of 3 quarters · filed 2016-02-26 | $279.55M 10-K · filed 2016-02-26 | $334.08M 10-K · filed 2014-02-27 | |||
| 2013-09-30 | $81.77M 10-Q · filed 2014-11-07 | $84.10M 10-Q · filed 2013-10-30 | $163.60M derived: sum of 2 quarters · filed 2014-11-07 | $243.21M 10-Q · filed 2014-11-07 | $247.44M 10-Q · filed 2013-10-30 | $325.14M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-06-30 | $81.83M 10-Q · filed 2014-08-05 | $83.07M 10-Q · filed 2013-08-01 | $161.44M 10-Q · filed 2014-08-05 | $163.34M 10-Q · filed 2013-08-01 | $243.37M derived: sum of 3 quarters · filed 2015-02-27 | $322.92M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-03-31 | $79.61M 10-Q · filed 2014-05-01 | $80.27M 10-Q · filed 2013-05-02 | $161.54M derived: sum of 2 quarters · filed 2015-02-27 | $241.09M derived: sum of 3 quarters · filed 2015-02-27 | $319.36M derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2012-12-31 | $81.93M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $161.48M derived: sum of 2 quarters · filed 2015-02-27 | $239.75M derived: sum of 3 quarters · filed 2015-02-27 | $314.43M 10-K · filed 2015-02-27 | ||||
| 2012-09-30 | $79.55M 10-Q · filed 2013-10-30 | $157.82M derived: sum of 2 quarters · filed 2013-10-30 | $232.50M 10-Q · filed 2013-10-30 | $315.24M derived: sum of 4 quarters · filed 2014-06-20 | ||||
| 2012-06-30 | $78.27M 10-Q/A · filed 2013-08-02 | $152.95M 10-Q/A · filed 2013-08-02 | $235.69M derived: sum of 3 quarters · filed 2014-06-20 | $314.34M derived: sum of 4 quarters · filed 2014-06-20 | ||||
| 2012-03-31 | $74.67M 10-Q · filed 2013-05-02 | $157.41M derived: sum of 2 quarters · filed 2014-06-20 | $236.07M derived: sum of 3 quarters · filed 2014-06-20 | $308.90M derived: sum of 4 quarters · filed 2014-06-20 | ||||
| 2011-12-31 | $82.74M derived: 8-K 12 month − 10-Q 9 month · filed 2014-06-20 | $161.39M derived: sum of 2 quarters · filed 2014-06-20 | $234.23M derived: sum of 3 quarters · filed 2014-06-20 | $299.15M 8-K · filed 2014-06-20 | ||||
| 2011-09-30 | $78.65M 10-Q · filed 2012-10-24 | $151.49M derived: sum of 2 quarters · filed 2012-10-24 | $216.41M 10-Q · filed 2012-10-24 | $287.72M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-06-30 | $72.84M 10-Q · filed 2012-07-31 | $137.76M 10-Q · filed 2012-07-31 | $209.06M derived: sum of 3 quarters · filed 2013-02-26 | $278.26M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-03-31 | $64.92M 10-Q · filed 2012-04-26 | $136.23M derived: sum of 2 quarters · filed 2013-02-26 | $205.42M derived: sum of 3 quarters · filed 2013-02-26 | $269.88M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2010-12-31 | $71.31M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $140.50M derived: sum of 2 quarters · filed 2013-02-26 | $204.96M derived: sum of 3 quarters · filed 2013-02-26 | $268.19M 10-K · filed 2013-02-26 | ||||
| 2010-09-30 | $69.19M 10-Q · filed 2011-10-31 | $133.66M derived: sum of 2 quarters · filed 2011-10-31 | $196.88M 10-Q · filed 2011-10-31 | $260.83M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2010-06-30 | $64.46M 10-Q · filed 2011-08-01 | $127.69M 10-Q · filed 2011-08-01 | $191.63M derived: sum of 3 quarters · filed 2012-02-27 | $254.65M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2010-03-31 | $63.22M 10-Q · filed 2011-04-28 | $127.17M derived: sum of 2 quarters · filed 2012-02-27 | $190.19M derived: sum of 3 quarters · filed 2012-02-27 | $249.99M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2009-12-31 | $63.94M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $126.97M derived: sum of 2 quarters · filed 2012-02-27 | $186.77M derived: sum of 3 quarters · filed 2012-02-27 | $244.92M 10-K · filed 2012-02-27 | ||||
| 2009-09-30 | $63.02M 10-Q · filed 2010-10-28 | $122.83M derived: sum of 2 quarters · filed 2010-10-28 | $180.97M 10-Q · filed 2010-10-28 | |||||
| 2009-06-30 | $59.80M 10-Q · filed 2010-07-29 | $117.95M 10-Q · filed 2010-07-29 | ||||||
| 2008-12-31 | $252.83M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |